ChemicalBook > CAS DataBase List > Deoxygalactonojirimycin Hydrochloride

Deoxygalactonojirimycin Hydrochloride

Product Name
Deoxygalactonojirimycin Hydrochloride
CAS No.
75172-81-5
Chemical Name
Deoxygalactonojirimycin Hydrochloride
Synonyms
DGJ;Amigal;GR181413A;GR 181413A;GR-181413A;5-Dideoxy-1;Migalastat HCl;Unii-cly7m0xd20;GALACTOSTATIN HCL;DGJ, HYDROCHLORIDE
CBNumber
CB5252941
Molecular Formula
C6H13NO4.ClH
Formula Weight
199.63
MOL File
75172-81-5.mol
More
Less

Deoxygalactonojirimycin Hydrochloride Property

Melting point:
260
storage temp. 
2-8°C
solubility 
Methanol (Slightly), Water (Slightly)
form 
White crystalline solid
color 
White to Brown
More
Less

Safety

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26-36
WGK Germany 
3
Hazard Note 
Irritant
HS Code 
29333990
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
D9641
Product name
Deoxygalactonojirimycin hydrochloride
Packaging
2mg
Price
$163
Updated
2024/03/01
Sigma-Aldrich
Product number
259544
Product name
Deoxygalactonojirimycin, Hydrochloride
Purity
Potent and selective α-galactosidase inhibitor.
Packaging
5mg
Price
$259
Updated
2022/05/15
Cayman Chemical
Product number
17179
Product name
1-Deoxygalactonojirimycin (hydrochloride)
Purity
≥98%
Packaging
1mg
Price
$44
Updated
2024/03/01
Cayman Chemical
Product number
17179
Product name
1-Deoxygalactonojirimycin (hydrochloride)
Purity
≥98%
Packaging
5mg
Price
$140
Updated
2024/03/01
Cayman Chemical
Product number
17179
Product name
1-Deoxygalactonojirimycin (hydrochloride)
Purity
≥98%
Packaging
10mg
Price
$235
Updated
2024/03/01
More
Less

Deoxygalactonojirimycin Hydrochloride Chemical Properties,Usage,Production

Description

Migalastat, which is marketed by Amicus Therapeutics, received approval in the EU for the treatment of Fabry disease in adults and adolescents aged 16 or older. Fabry disease is caused by mutations of the enzyme α-galactosidase A (α-GAL A) that cause protein misfolding and prevents efficient metabolism of the glycosphingolipid globotriaosylceramide (GL3). Accumulation of GL3 in lysosomes, blood vessels, and various tissues ultimately leads to significant heart, kidney, and dermatological problems. Migalastat functions as a molecular chaperone to α- GAL A, engaging the enzyme and enabling it to adopt the proper conformation allowing for efficient breakdown of GL3. Because the standard of care prior to 2016 for treating Fabry disease was enzyme replacement therapy (ERT), migalastat’s approval in the EU represents an important advance for patients suffering from this disorder.

Chemical Properties

White Crystalline Solid

Uses

Proven to be an extremely potent and selective a-D-galactosidase inhibitor.

Uses

inhibitor of b-glucosidase

Uses

Deoxygalactonojirimycin hydrochloride has been used as an α-galactosidase A inhibitor to assess the enzymatic activity of α-galactosidase A. It has also been used as an α-galactosidase A inhibitor to study its effects on the mRNA levels in human embryonic kidney (HEK) cells and hippocampal neurons.

brand name

Treatment of Fabry disease.

Biochem/physiol Actions

Deoxygalactonojirimycin hydrochloride is an inhibitor of α-galactosidase A. Deoxygalactonojirimycin exhibits therapeutic effects against Fabry disease.

Synthesis

Several unique synthetic approaches to migalastat, which is also known as D-1-deoxygalactonojirimycin (DGJ), have been reported in the literature. Although the most likely commercial-scale preparation of this drug proceeds through a microbial fermentation process disclosed in a 2015 patent, a kilogram-scale synthesis of the drug outlined has been described in a 2008 patent application filed by Amicus. This route closely resembles a procedure disclosed in 1999 by Uriel and Santoyo-Gonzalez that presented handling and safety concerns. Commercial D-galactose (143) was treated with five equivalents of pivaloyl imidazole (144), followed by triflation, treatment with Hunig?ˉs base, and exposure to sodium nitrite to furnish the tetrapivaloyl altofuranose triflate 145 after recrystallization from heptane. Next, stereospecific azide displacement of the triflate successfully delivered azidofuranose 146 in 65-70% yield. This reaction generated over 3 kg of the desired alkyl azide after recrystallization from ethanol and water. Lastly, palladium-catalyzed hydrogenolysis in the presence of sodium methoxide, a methanolic acidification step, and then a subsequent acidification step using HCl in THF furnished migalastat hydrochloride (XV) in 70-75% yield over the three-step sequence from 146.

target

α-galactosidase

IC 50

40 nm

References

[1] asano n, ishii s, kizu h, et al. in vitro inhibition and intracellular enhancement of lysosomal α‐galactosidase a activity in fabry lymphoblasts by 1‐deoxygalactonojirimycin and its derivatives[j]. febs journal, 2000, 267(13): 4179-4186.
[2] ishii s, chang h, yoshioka h, et al. preclinical efficacy and safety of 1-deoxygalactonojirimycin in mice for fabry disease[j]. journal of pharmacology and experimental therapeutics, 2009, 328(3): 723-731.

Deoxygalactonojirimycin Hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Deoxygalactonojirimycin Hydrochloride Suppliers

SIGMA-RBI
Tel
--
Fax
--
Country
Switzerland
ProdList
6896
Advantage
91
Alexis Corporation
Tel
--
Fax
--
Email
alexis-ch@alexis-corp.ch
Country
Switzerland
ProdList
3599
Advantage
74
More
Less

View Lastest Price from Deoxygalactonojirimycin Hydrochloride manufacturers

WUHAN FORTUNA CHEMICAL CO., LTD
Product
Migalastat HCl 75172-81-5
Price
US $0.00/G
Min. Order
10G
Purity
98%min
Supply Ability
30kg/month
Release date
2023-02-15
NewCan Biotech Limited
Product
Migalastat Hydrochloride 75172-81-5
Price
US $0.00-0.00/g
Min. Order
1g
Purity
98%
Supply Ability
10kg
Release date
2024-07-17
Career Henan Chemical Co
Product
DEOXYGALACTONOJIRIMYCIN, HYDROCHLORIDE 75172-81-5
Price
US $1.00/KG
Min. Order
1KG
Purity
98
Supply Ability
200kg
Release date
2019-09-10

75172-81-5, Deoxygalactonojirimycin HydrochlorideRelated Search:


  • 1,5-DIDEOXY-1,5-IMINO-D-GALACTITOL, HYDROCHLORIDE
  • 1-DEOXYGALACTONOJIRIMYCIN HCL
  • DEOXYGALACTONOJIRIMYCIN HCL
  • DEOXYGALACTONOJIRIMYCIN, HYDROCHLORIDE
  • DGJ
  • DGJ, HYDROCHLORIDE
  • GALACTOSTATIN HCL
  • 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, hydrochloride, (2R,3S,4R,5S)-
  • 1,5-dideoxy-1,5-imino-d-galactitol
  • 5-Dideoxy-1
  • 5-imino-D-galactitol
  • AT1001; AT 1001; AT-1001; GR181413A; GR 181413A; GR-181413A; 1;5-DIDEOXY-1;5-IMINO-D-GALACTITOL; 1-DEOXYGALACTONOJIRIMYCIN; 1-DEOXYGALACTOSTATIN; AMIGAL; MIGALASTAT
  • GR 181413A
  • GR181413A
  • GR-181413A
  • Deoxygalactonojirimycin, Hydrochloride - CAS 75172-81-5 - Calbiochem
  • 1-Deoxygalactonojirimycin, hydrochloride, Min. 98%
  • Galactostatin hydrochloride
  • Amigal
  • Migalastat hydrochloride
  • Unii-cly7m0xd20
  • 1-Deoxygalactonojirimycin Hydrochloride
  • (2R,3S,4R,5S)-2-(Hydroxymethyl)piperidine-3,4,5-triol hydrochloride
  • Galactostatin hydrochloride, Deoxygalactonojirimycin hydrochloride
  • (2R,3S,4R,5S)-2-HydroxyMethyl-3,4,5-piperidinetriol Hydrochloride
  • 1-Deoxygalactostatin Hydrochloride
  • Migalastat HCl
  • 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, hydrochloride (1:1), (2R,3S,4R,5S)-
  • 75172-81-5
  • C6H13NO4ClH
  • Enzymes, Inhibitors, and Substrates
  • Enzyme Inhibitors
  • Enzyme Inhibitors by Enzyme
  • D to K
  • Galactosidase, alpha-
  • BioChemical
  • Biochemicals and Reagents
  • 13C & 2H Sugars
  • Carbohydrates & Derivatives
  • Glycosidase Inhibitors
  • Inhibitors